To assess whether dysregulated expression of CCND2, HOXC6, PLXNA1 and VEGFA correlates with clinical outcome, Kaplan Meier analyses were completed using microarray gene expression data from primary ERMS and ARMS [23]. The gene discussed is HOXC6; the disease is alveolar rhabdomyosarcoma.